About NBR“Nightly Business Report produced by CNBC” (NBR) is an award-winning and highly-respected nightly business news program that airs on public television. Television’s longest-running evening business news broadcast, “NBR” features in-depth coverage and analysis of the biggest financial news stories of the day and access to some of the world’s top business leaders and policy makers.
- Asian shares tread water following softer lead from Wall Street
- The 401(k) debacle proves why sweeping tax reform will be hard to pass, Cramer says
- Emerging opportunity? Why the 'trade of the year' may still have room to run
- Nimble will let you schedule prescription deliveries while at the doctor's office
- Toys R Us bankruptcy won't stop Hasbro from selling its toys there, Hasbro CEO says
NBR on TwitterMy Tweets
Subscribe to RSS
Scientists are inching toward developing a vaccine for AIDS, an immunodeficiency disease caused by the HIV virus that currently affects 36.7 million people worldwide, according to the World Health Organization.
Trump’s order comes after months of failed efforts by the president and Republicans to get Obamacare repeal legislation passed by Congress.
Typical errors made during open enrollment could leave you with the wrong plan come Jan. 1.
As Americans live longer, demand for health-care workers is growing. Employers are getting creative to meet their needs.
As the unemployment rate for the health care industry sits below the national average, hospitals and home health care firms are having difficulty attracting top talent. Bertha Coombs reports.
Cancer patients and people in hospice who already have OxyContin prescriptions will continue to have the drug covered in 2018, Cigna said.
Kymriah uses a patient’s own cells as medicine. But this historic treatment comes with a historic price.
Allergan is urging the Senate Judiciary Committee to review the patent challenge system it’s been accused of thwarting.
State budgets would be hurt by the latest GOP health care proposal, with the biggest pain felt by mostly blue states that expanded Medicaid coverage.
Researchers are testing MDMA, known as ecstasy, to treat depression in people who do not respond to current antidepression drugs.
Engineers and scientists at the University of Texas unveil a diagnosis breakthrough.
ChemoWave helps patients track a wide variety of medical data like symptoms, exercise, water intake and medications.
Health insurer Aetna has hired Ben Wanamaker from Wal-Nart’s health division to lead its joint venture with Apple, according to a source.
The settlement came after an unusual lawsuit by Sanofi, a competitor to Mylan, which alleged anti-competitive tactics.
Goldman Sachs added biotech company Biogen to its Americas Conviction List, citing a ‘blockbuster’ drug.